John Kiely
Director · Amneal Pharmaceuticals, Inc.
IndividualSelling only
- 2024
- Aug 14, 2026
- 4
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies John Kiely files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Nikita Shah - $4.14M in AMRX purchases and sales in the last 12 months
- Jason B. Daly - $3.77M in AMRX purchases and sales in the last 12 months
- Ted C. Nark - $586K in AMRX purchases and sales in the last 12 months
- Deborah M. Autor - $451K in AMRX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is John Kiely?
John Kiely is a corporate insider, tracked as Director of Amneal Pharmaceuticals, Inc. (AMRX). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has John Kiely submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has John Kiely been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($1.32M) across all tracked filings.
